According to IMARC Group’s latest report, titled “Opioids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global opioids market size reached a value of US$ 20.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 24.9 Billion by 2027, exhibiting at a CAGR of 3.3% during 2022-2027.

Opioids refer to a set of drugs that act on the nervous system to relieve pain, which include prescription medications, such as oxycodone, hydrocodone, and fentanyl, as well as illegal drugs, such as heroin. They work by binding to specific receptors in the brain and spinal cord, thus reducing the perception of pain and producing feelings of euphoria. They are commonly prescribed for the management of acute and chronic pain, but can also be misused and abused, leading to addiction and overdose. Opioid addiction has emerged as a major public health concern in recent years, prompting efforts to improve prescription practices, expand access to treatment, and develop alternative pain management options.

Request For a Free PDF Sample Report: https://www.imarcgroup.com/opioids-market/requestsample

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

Opioids Market Trends:

The increasing prevalence of chronic pain conditions, such as cancer pain and arthritis, represents a key factor driving the growth of the market across the globe. In line with this, the rising cases of opioid addiction and abuse are facilitating the demand for treatment options, such as methadone and buprenorphine, which are further contributing to the growth of the market. The market is also driven by governments in several countries introducing regulations to address the rising concern of opioid addiction and abuse. These regulations are driving the demand for alternative pain management options, such as non-opioid painkillers and medical cannabis, thus facilitating the market growth. Other factors, such as the expanding aging population base, an increase in the number of surgeries and trauma cases, and rising approval and the launch of new opioid medicines to treat patients, are creating a positive outlook for the market.

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

  • Boehringer Ingelheim International GmbH
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt plc
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Key Market Segmentation:

The report has categorized the market based on product type, application, distribution channel and region.

Breakup by Product Type:

  • Codeine 
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone

Breakup by Application:

  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Key Highlights of The Report:                                                    

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St.

Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800